Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications | Zendy

Federico Mazza | Zendy; Enrico Ferrari | Zendy; Paola Maineri | Zendy; Massimiliano Venturino | Zendy; Béatrice Dozin | Zendy; Giovanni Battista Ratto | Zendy

AI Assistant Blog Pricing

Open Access

Pulmonary middle lobectomy for non-small-cell lung cancer: effectiveness and prognostic implications

Author(s) -

Federico Mazza,

Enrico Ferrari,

Paola Maineri,

Massimiliano Venturino,

Béatrice Dozin,

Giovanni Battista Ratto

Publication year - 2015

Publication title -

european journal of cardio-thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.303

H-Index - 133

eISSN - 1873-734X

pISSN - 1010-7940

DOI - 10.1093/ejcts/ezv314

Subject(s) - medicine , dissection (medical) , lung cancer , lymph node , mediastinal lymph node , pathological , stage (stratigraphy) , lung , homogeneous , surgery , gastroenterology , oncology , cancer , biology , metastasis , paleontology , physics , thermodynamics

The therapeutic value of pulmonary middle lobectomy (PML) has been questioned. PML is currently regarded as a standard form of lobectomy, even so it shares some surgical features with segmentectomies (SEG) more than with lobectomies. The present study's aim was to assess the therapeutic value of PML with respect to other lobectomies (LOBs) and SEGs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog